A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein Cholesterol
The American Journal of Human Genetics2006Vol. 78(3), pp. 410–422
Citations Over TimeTop 1% of 2006 papers
Ingrid K. Kotowski, Alexander Pertsemlidis, Amy Luke, Stephen S. Rich, Gloria Lena Vega, Jonathan C. Cohen, Helen H. Hobbs
Related Papers
- → Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)(2013)231 cited
- → On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects(2014)80 cited
- → A New Strategy for Rapidly Screening Natural Inhibitors Targeting the PCSK9/LDLR Interaction In Vitro(2018)15 cited
- → Development and functional analysis of novel PCSK9/LDLR interaction inhibitors for hypercholesterolemia treatment(2021)
- → Structural Dynamics of LDL Receptor Interactions with E498A and R499G Variants of PCSK9(2024)